In a report released today, Joanne Wuensch from Citi maintained a Hold rating on Haemonetics (HAE – Research Report). The company’s shares closed yesterday at $75.05. Discover outperforming ...

Why do we make rock biopics – and why do we watch them – unless it’s to see the deeply familiar parts of our collective culture playing out over and over, with varying degrees of success. One of the ...

If you’re on the fence about investing in Haemonetics Corporation or Glaukos Corporation ... and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related ...

(RTTNews) - Haemonetics Corporation (HAE), a provider in medical technology focused on advancing patient outcomes, Tuesday announced that it has finalized the sale of its whole blood assets to GVS ...

BOSTON, Jan. 14, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes ...

After all, from the invention of the cotton gin to the washing machine, we’re used to an ... surprised over the last several years how many parts of science, at least in part, can have big ...

Haemonetics (NYSE:HAE) announced today that it has completed its previously announced sale of its whole blood assets to GVS S.p.A. The sale has a total cash consideration of up to $67.8 million ...

BOSTON, Jan. 14, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, ...